3649 results for «480»
3649 results
Rapid-fire - Challenging TAVI procedures - Part 1
19 Nov 2023 – From PCR London Valves 2023
Discover challenging TAVI procedures in this session, including: TAVI in a small aortic annulus with chimney stenting, TAVI with ACURATE Neo 2 and coronary protection in a horizontal aorta with low coronary height, simultaneous kissing balloon inflation technique for effective coronary protection during TAVI, and much...
Rapid-fire - TAVI complications - Part 1
19 Nov 2023 – From PCR London Valves 2023
Delve into complex TAVI situations with this session: a TAVR that won't open, an heavily calcified aortic stenosis with bridged calcium between valve leaflet, a severe aortic stenosis coupled with triple vessel disease, a TAVI pop-out incident, and more!
Innovations in transcatheter tricuspid valve intervention - LIVE case
21 Nov 2023 – From PCR London Valves 2023
Consult this session to discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.
- LIVE case: An 81-year-old woman with permanent AF presents a symptomatic torrential TR with right...
Key questions in aortic valve intervention - Anticoagulation after TAVI - when, and for whom?
21 Nov 2023 – From PCR London Valves 2023
Tune in to this session focused on post-TAVI anticoagulation, where the cases of three TAVI patients are explored. Analyze and determine the optimal antithrombotic strategy for each situation: the first patient in sinus rhythm, the second with atrial fibrillation, and the third with atrial fibrillation undergoing...
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
SIRONA completes enrollment! A leap in the DCB treatment of femoropopliteal arterial disease
02 Nov 2022
When transfemoral TAVI is not an option: rethinking alternative access strategies
18 Jun 2026
In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...
Author
